Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Heparin-binding Protein and Heparins

NCT04146493 is registered in ClinicalTrials.gov with Halla Halldorsdottir as lead sponsor.

NCT NCT04146493
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04146493 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Heparin-binding Protein and Heparins
Lead sponsor
Halla Halldorsdottir
Phase
Observational
Overall status
Completed
Start date
April 1, 2019
Completion date
November 30, 2021
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, thromboprophylaxis, vascular disease, peripheral